Live AusBiotech updates | Page 12
Live AusBiotech news coverage of developments with the latest updates. Stay on top of latest AusBiotech news stories and find out what just happened, what is going on with AusBiotech. The latest real-time news updates and headlines on AusBiotech
First subjects randomised and dosed in Paradigm's late-stage trial
28 Apr 2022 2:13 pm AEST
Adherium releases next generation respiratory platform integration services
28 Apr 2022 2:12 pm AEST
Opthea announces appointment of two new directors
26 Apr 2022 4:18 pm AEST
New UK-based business development for Adherium
26 Apr 2022 4:18 pm AEST
NSW Government seeks operator for RNA manufacturing
26 Apr 2022 4:10 pm AEST
Medlab Clinical confirms northern hemisphere distribution
21 Apr 2022 2:50 pm AEST
Volpara Health announces leadership and board changes
21 Apr 2022 2:48 pm AEST
Mission to BioKorea to strengthen ties
21 Apr 2022 2:34 pm AEST
EpiAxis Therapeutics appoints new chief science officer
19 Apr 2022 2:16 pm AEST
Zelria Therapeutics executes acquisition of Health House
19 Apr 2022 2:16 pm AEST
Botanix confirms presentation of data at upcoming congress
14 Apr 2022 2:16 pm AEST
Imugene says first cohort two patient dose in phase 1 clinical trial
14 Apr 2022 2:16 pm AEST
Microbio is step closer to launching its InfectID-BSI tests in Europe
12 Apr 2022 3:09 pm AEST
Rhonomed completes institutional component of capital raise
12 Apr 2022 3:09 pm AEST
Australian Pavilion returns in-person to BIO 2022
12 Apr 2022 2:12 pm AEST
MTPConnect announces support for major new resilience projects
07 Apr 2022 2:36 pm AEST
Race receives human ethics approval for new trial
07 Apr 2022 2:36 pm AEST
Microba announces new research partnership and senior appointment
05 Apr 2022 2:26 pm AEST
Australian healthcare investor urges greater support from peers
05 Apr 2022 2:18 pm AEST
Avecho reports positive results for Phase 2 topical CBD osteoarthritis study
01 Apr 2022 9:34 am AEDT
NTCELL to be produced in Australia under UTS research agreement
01 Apr 2022 8:46 am AEDT
Government launches biotechnology - strategic plan for health and medicine
31 Mar 2022 2:18 pm AEDT
Dimerix receives R&D tax rebate for last financial year
29 Mar 2022 2:24 pm AEDT
Neuren receives FDA approval for Pitt Hopkins IND and Phase 2 trial
29 Mar 2022 2:24 pm AEDT
BioScience Managers welcomes FDA approval of Saluda technology
24 Mar 2022 2:14 pm AEDT
Large molecule facility doubles size of leading bioanalytical laboratory
24 Mar 2022 2:14 pm AEDT
Industry concerned by leaked Covid vaccine IP waiver text
24 Mar 2022 2:05 pm AEDT
Biotron updates on pre-clinical study of BIT225 in Covid
22 Mar 2022 3:16 pm AEDT
US FDA grants new orphan designation to Noxopharm's Veyonda
22 Mar 2022 3:16 pm AEDT
Access savings by registering early for AusMedtech 2022
22 Mar 2022 2:21 pm AEDT
Australia and Korea sign MoU on vaccine research
18 Mar 2022 11:00 am AEDT
Paradigm secures UK approvals for PARA_OA_002 clinical trial
17 Mar 2022 4:28 pm AEDT
First Participants dosed in ENA Respiratory's phase 2a study
17 Mar 2022 4:20 pm AEDT
WA funding programmes open
17 Mar 2022 4:11 pm AEDT
Neuren receives ethics approval for Angelman Phase 2 trial
16 Mar 2022 8:22 am AEDT
'Gold standard' commercialisation for biotech
16 Mar 2022 8:06 am AEDT
Partnership encourages innovation in how universities and industry collaborate
14 Mar 2022 12:56 pm AEDT
Partnership encourages innovation in how Australian universities and industry collaborate
14 Mar 2022 5:46 am AEDT
Telix's ZIRCON late-stage kidney cancer imaging study completes enrolment
11 Mar 2022 11:58 am AEDT
Rebrand for Australia's largest life sciences venture fund
11 Mar 2022 11:58 am AEDT
Victoria's Medtech Manufacturing Capability Programme opens
11 Mar 2022 11:43 am AEDT
Recognition for Vetter in CMO Leadership Awards
08 Mar 2022 3:50 pm AEDT
Chimeric Therapeutics announces final results from Phase 1 trial of CORE NK Platform
08 Mar 2022 3:50 pm AEDT
International Women's Day: AusBiotech 'moving dial' on gender equity
08 Mar 2022 3:02 pm AEDT
Antisense Therapeutics confirms ATL1102 poster presentation
04 Mar 2022 8:42 am AEDT
New expedited regulatory pathway proposed for novel biologicals
04 Mar 2022 8:18 am AEDT
Approval for Neuren Pharmaceuticals' Phase 2 trial in Angelman syndrome
02 Mar 2022 1:04 pm AEDT
Patrys selects stable cell line for production of PAT-DX3
02 Mar 2022 12:48 pm AEDT